Related Experiment Video
Updated: Oct 4, 2025

11:54
Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
9.1K
Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients
Nischay Mishra1, James Ng1, Mark A Strom2
1Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York.
JAMA Dermatology
|February 9, 2022
Summary
Human polyomavirus 9 caused severe skin disease and organ failure in three solid organ transplant recipients. This study highlights the critical need for identifying novel pathogens in immunocompromised patients.
Area of Science:
- Virology
- Immunology
- Dermatology
Background:
- Solid organ transplant recipients are susceptible to opportunistic infections.
- Human polyomaviruses are known to cause disease in immunocompromised individuals.
Purpose of the Study:
- To report the first known cases of cutaneous and systemic disease caused by human polyomavirus 9 (HPyV9) in solid organ transplant recipients.
- To investigate the role of HPyV9 in a fatal, widespread skin eruption.
Main Methods:
- A case series of three solid organ transplant recipients with unexplained skin lesions.
- High-throughput sequencing of lesional skin biopsies.
- In situ hybridization and quantitative PCR assays on various patient samples and autopsy tissues.
Main Results:
- HPyV9 was identified in skin biopsies from all three patients.
- HPyV9 DNA and mRNA were detected in multiple tissues, including skin, blood, and lungs, indicating active viral replication.
- All patients developed progressive cutaneous disease and died from multiorgan failure.
Conclusions:
- HPyV9 is associated with a severe, progressive cutaneous eruption and systemic disease in solid organ transplant recipients.
- The findings suggest HPyV9 can cause fatal pulmonary and multiorgan failure.
- Early identification and understanding of HPyV9 pathogenesis are crucial for managing immunocompromised patients.
Related Concept Videos
Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K
Tissue Transplantation
551
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
551

